死亡したドナーの腎臓移植 移植前の悪性腫瘍の候補者:文献レビューとシンガポールの受容者割り当て提案
Emmett Tsz Yeung Wong1,2, Ian Tatt Liew3,4, Hein Than5,6,7
1Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Level 8, NUHS Tower Block, 1E Kent Ridge Road, Singapore, 119228, Singapore. e.wong@nus.edu.sg.
Journal of nephrology
|August 22, 2025
まとめ
血液学的悪性腫瘍の病歴のある患者は,稀なドナー臓器であっても,腎臓移植を受ける資格があります. このレビューは,シンガポールの候補者評価と臓器配分最適化のためのガイドラインを提供します.
科学分野:
- 腎臓科
- 血液学
- 移植免疫学
背景:
- 死んだドナーの腎臓は 稀なので 倫理的原則に基づいて 慎重に配分する必要があります
- 以前悪性腫瘍を患った腎臓移植受容者は 高い死亡リスクに直面し 資源配分に関する疑問を提起しています
- 血液学的悪性腫瘍の治療における進歩は,患者の生存率を改善し,最新の専門家の意見を促しました.
研究 の 目的:
- 血液学的悪性病歴のある患者の腎臓移植の評価と応募推奨事項のレビュー
- シンガポールの 稀な死者の臓器の配分を最適化するためです
- 臓器の不足や長期の待機時間を 移植候補者の評価に考慮すること
主な方法:
- 移植前の悪性腫瘍と腎臓移植の結果に関する既存の文献のレビュー.
- アメリカ移植協会のガイドラインを含む最新のコンセンサス専門家の意見の分析
- 臓器不足の問題を抱える国からの証拠の検討
主要な成果:
- 血液学的悪性腫瘍患者の生存率の改善は,移植候補者の再評価を正当化します.
- 臓器不足の領域における血液学的悪性腫瘍の患者については,特別な注意が必要である.
- シンガポールの状況に合わせた勧告が提案され,一般化の可能性のある制限が認められています.
結論:
- 死亡したドナーの腎臓移植に適した候補者は,過去に血液学的悪性腫瘍を患っていた患者である.
- 資源の限られた環境で 臓器の配分を最適化するには 慎重に評価し 調整された推奨が不可欠です
- このコンセンサスレポートは,シンガポールにおける意思決定の枠組みを提供し,同様のグローバルな課題に適応できます.
関連する概念動画
Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
Kidney Transplant II: Surgical Procedure
75
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
75
Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Tissue Transplantation
519
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
519
Kidney Transplant III: Nursing Management
81
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
81


